Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.8912
+0.0078 (0.88%)
Jun 25, 2025, 4:00 PM - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $35.95 million as of June 26, 2025. Its market cap has decreased by -51.40% in one year.
Market Cap
35.95M
Enterprise Value
-51.25M
1-Year Change
-51.40%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $35.95M, a decrease of -93.79%. That is a compound annual growth rate of -48.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 35.64M | -26.67% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |